1E Therapeutics raised $120M seed funding to develop RNA-targeting therapies
Biospace - 09-Dec-2021Biotech experts back 1E, believing it can transform medical treatments
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Freelance writer
Alvin Clavines writes for BioSpace, contributing articles focused on biotechnology and life sciences. His work covers industry insights and trends.
Visit website: https://www.biospace.com/alvin-clavines
See alsoDetails last updated 13-Nov-2024
Biotech experts back 1E, believing it can transform medical treatments